| Symbol |
Name |
|
ABCF1
|
ATP-binding cassette, sub-family F (GCN20), member 1
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AIRE
|
autoimmune regulator
|
|
ARL15
|
ADP-ribosylation factor-like 15
|
|
ASNA1
|
arsA arsenite transporter, ATP-binding, homolog 1 (bacterial)
|
|
B2M
|
beta-2-microglobulin
|
|
BAG6
|
BCL2-associated athanogene 6
|
|
BTNL2
|
butyrophilin-like 2
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CD19
|
CD19 molecule
|
|
CD4
|
CD4 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD8A
|
CD8a molecule
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
DSG1
|
desmoglein 1
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAS
|
Fas cell surface death receptor
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GP6
|
glycoprotein VI (platelet)
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HFE
|
hemochromatosis
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF2
|
insulin-like growth factor 2
|
|
IL10
|
interleukin 10
|
|
IL12B
|
interleukin 12B
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL23R
|
interleukin 23 receptor
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL4
|
interleukin 4
|
|
IL7R
|
interleukin 7 receptor
|
|
INS
|
insulin
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
JAK2
|
Janus kinase 2
|
|
KDM5D
|
lysine (K)-specific demethylase 5D
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIR3DL2
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
|
|
KIR3DS1
|
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LILRA3
|
leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LST1
|
leukocyte specific transcript 1
|
|
LTA
|
lymphotoxin alpha
|
|
MAGEA1
|
melanoma antigen family A1
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MLH1
|
mutL homolog 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PML
|
promyelocytic leukemia
|
|
PRKCD
|
protein kinase C, delta
|
|
PRSS16
|
protease, serine, 16 (thymus)
|
|
PSMB10
|
proteasome (prosome, macropain) subunit, beta type, 10
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)
|
|
PSME2
|
proteasome (prosome, macropain) activator subunit 2 (PA28 beta)
|
|
PSORS1C1
|
psoriasis susceptibility 1 candidate 1
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
|
SATB1
|
SATB homeobox 1
|
|
SCGB2A2
|
secretoglobin, family 2A, member 2
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC44A2
|
solute carrier family 44 (choline transporter), member 2
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAPBP
|
TAP binding protein (tapasin)
|
|
TCF19
|
transcription factor 19
|
|
TERT
|
telomerase reverse transcriptase
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TLR2
|
toll-like receptor 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF19
|
tumor necrosis factor receptor superfamily, member 19
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TP63
|
tumor protein p63
|
|
TPP2
|
tripeptidyl peptidase II
|
|
TRB
|
T cell receptor beta locus
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
WT1
|
Wilms tumor 1
|
|
XAGE1B
|
X antigen family, member 1B
|
